BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 253 filers reported holding BIONTECH SE in Q3 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,566,204 | -2.7% | 42,267 | -2.8% | 0.01% | -14.3% |
| Q2 2023 | $4,691,833 | -25.0% | 43,472 | -13.5% | 0.01% | -30.0% |
| Q1 2023 | $6,252,334 | +4.4% | 50,277 | +27.0% | 0.01% | 0.0% |
| Q4 2022 | $5,986,742 | +3.3% | 39,595 | -7.8% | 0.01% | -9.1% |
| Q3 2022 | $5,798,000 | -9.5% | 42,937 | -0.1% | 0.01% | -8.3% |
| Q2 2022 | $6,409,000 | -4.1% | 42,992 | +9.8% | 0.01% | +20.0% |
| Q1 2022 | $6,680,000 | -18.8% | 39,158 | +20.2% | 0.01% | -16.7% |
| Q4 2021 | $8,230,000 | +55.8% | 32,590 | +68.7% | 0.01% | +50.0% |
| Q3 2021 | $5,282,000 | +29.4% | 19,323 | +6.0% | 0.01% | +14.3% |
| Q2 2021 | $4,082,000 | -37.6% | 18,235 | -69.6% | 0.01% | -41.7% |
| Q1 2021 | $6,541,000 | +1461.1% | 59,906 | +1116.9% | 0.01% | +1100.0% |
| Q4 2020 | $419,000 | +54.0% | 4,923 | +25.5% | 0.00% | 0.0% |
| Q3 2020 | $272,000 | +34.7% | 3,923 | +29.3% | 0.00% | 0.0% |
| Q2 2020 | $202,000 | +14.1% | 3,033 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $177,000 | – | 3,033 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 148,674 | $16,151,943 | 19.26% |
| Quinn Opportunity Partners LLC | 659,383 | $71,635,369 | 9.22% |
| Systrade AG | 50,000 | $5,432,000 | 4.70% |
| Crocodile Capital Partners GmbH | 29,586 | $3,214,223 | 3.03% |
| ALTRINSIC GLOBAL ADVISORS LLC | 700,421 | $76,093,737 | 2.94% |
| Temasek Holdings (Private) Ltd | 4,518,080 | $490,844,211 | 2.92% |
| PARUS FINANCE (UK) Ltd | 25,662 | $2,787,920 | 1.74% |
| FLOSSBACH VON STORCH AG | 3,513,215 | $381,675,678 | 1.68% |
| AtonRa Partners | 4,707 | $511,368 | 1.07% |
| Baader Bank Aktiengesellschaft | 135,093 | $14,617,456 | 0.99% |